Thor Medical ASA (OSL:TRMED)
Norway · Delayed Price · Currency is NOK 4.785
+0.085 (1.81%)
Sep 14, 2026, 1:14 PM CET
Thor Medical ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Operating Revenue | 1.24 | 0.44 | - | - | - |
Other Revenue | 0.4 | 0.4 | - | - | - |
| 1.64 | 0.84 | - | - | - | |
Revenue Growth | 1539.00% | - | - | - | - |
Gross Profit | 1.64 | 0.84 | - | - | - |
Selling, General & Admin | 37.85 | 29.65 | 13.29 | 3.14 | - |
Other Operating Expenses | 22.52 | 19.92 | 28.26 | 3.69 | - |
Operating Expenses | 84.49 | 70.49 | 43.93 | 7.16 | - |
Operating Income | -82.85 | -69.65 | -43.93 | -7.16 | - |
Interest Expense | -9.7 | -0.6 | -0.1 | - | - |
Interest & Investment Income | 6.63 | 6.63 | 1.45 | 2.02 | - |
Currency Exchange Gain (Loss) | -1.24 | 1.36 | 0.24 | -0.25 | - |
Other Non Operating Income (Expenses) | -0.1 | 0 | -0.3 | -0.17 | - |
Pretax Income | -87.27 | -62.27 | -42.64 | -5.56 | - |
Income Tax Expense | -4.26 | -4.26 | -0.43 | - | - |
Earnings From Continuing Operations | -83.01 | -58.01 | -42.21 | -5.56 | - |
Earnings From Discontinued Operations | - | - | - | -21 | -311.24 |
Net Income | -83.01 | -58.01 | -42.21 | -26.56 | -311.24 |
Net Income to Common | -83.01 | -58.01 | -42.21 | -26.56 | -311.24 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 356 | 332 | 236 | 175 | 115 |
Shares Outstanding (Diluted) | 356 | 332 | 236 | 175 | 115 |
Shares Change | 29.88% | 40.80% | 34.90% | 51.82% | - |
EPS (Basic) | -0.23 | -0.17 | -0.18 | -0.15 | -2.70 |
EPS (Diluted) | -0.23 | -0.17 | -0.18 | -0.15 | -2.70 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Free Cash Flow | -236.75 | -120.65 | -24.12 | -64.09 | -414.71 |
Free Cash Flow Per Share | -0.67 | -0.36 | -0.10 | -0.37 | -3.60 |
Gross Margin | 100.00% | 100.00% | - | - | - |
Operating Margin | -5055.10% | -8301.91% | - | - | - |
Profit Margin | -5064.80% | -6914.42% | - | - | - |
Free Cash Flow Margin | -14444.66% | -14379.98% | - | - | - |
EBITDA | -60.13 | -50.13 | -41.96 | -6.83 | - |
D&A For EBITDA | 22.72 | 19.52 | 1.97 | 0.33 | - |
EBIT | -82.85 | -69.65 | -43.93 | -7.16 | - |
Revenue as Reported | 0.84 | 0.84 | - | - | - |